Results 241 to 250 of about 749,314 (382)
High-dose cytosine arabinoside and mitoxantrone: a highly effective regimen in refractory acute myeloid leukemia [PDF]
Wolfgang Hiddemann+8 more
openalex +1 more source
c-fms expression is a molecular marker of human acute myeloid leukemias [PDF]
Patrice Dubreuil+4 more
openalex +1 more source
ABSTRACT Background Myeloproliferative neoplasms (MPN) are associated with an increased cardiovascular risk including acute coronary syndrome. However, there is a lack of comprehensive data regarding the rate of percutaneous coronary intervention (PCI), as well as the in‐hospital characteristics and outcomes for MPN patients.
Song Peng Ang+8 more
wiley +1 more source
Chronic myelomonocytic leukemia with NPM1 mutation or acute myeloid leukemia? [PDF]
Castaño-Díez S+26 more
europepmc +1 more source
8;21 Translocation in acute myeloid leukemia an ultrastructural study [PDF]
Guido Tricot, A. Broeckaert van Orshoven
openalex +1 more source
Mitochondria‐Catalyzed Activation of Anticancer Prodrugs
Mitochondria mediate electron transport chain (ETC) to power ATP synthase. In cancer cells, the ETC is disturbed leading to leakage of electron that ultimately results in generation of H2O2. This difference between cancer and healthy cells can be used for the design of cancer‐specific prodrugs as confirmed in several proof‐of‐concept studies ...
Michael Raucheisen+7 more
wiley +1 more source
Dysregulation of sphingolipid metabolism contributes to the pathogenesis of chronic myeloid leukemia. [PDF]
Xie Y+8 more
europepmc +1 more source
DNA aneuploidies in adult patients with acute myeloid leukemia. Incidence and relation to patient characteristics and morphologic subtypes [PDF]
Wolfgang Hiddemann+3 more
openalex +1 more source
Contemporary Perspectives on Chronic Renal Disorders
ABSTRACT The prevalence of renal diseases and its associated burden on healthcare have tremendously risen in the past few years. From simple markers assessing kidney function, current renal research delves into understanding the diseases at the cellular and molecular levels and not just at treating, but at improving quality of life, arresting ...
Deenadhayalan Ashok+5 more
wiley +1 more source